☰

Allan E. David, Ph.D. - Publications

Affiliations: 
2004 University of Maryland, College Park, College Park, MD 
Area:
Biomedical, Ophthalmology
Tree Info Similar researchers PubMed Report error

42 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Fan X, Torres-Luna C, Azadi M, Domszy R, Hu N, Yang A, David AE. Evaluation of commercial soft contact lenses for ocular drug delivery: a review. Acta Biomaterialia. PMID 32853799 DOI: 10.1016/J.Actbio.2020.08.025  0.306
2020 Yeh BJ, Anani T, David AE. Improving the Size Homogeneity of Multicore Superparamagnetic Iron Oxide Nanoparticles. International Journal of Molecular Sciences. 21. PMID 32423113 DOI: 10.3390/Ijms21103476  0.379
2019 Fan X, Domszy RC, Hu N, Yang AJ, Yang J, David AE. Synthesis of silica-alginate nanoparticles and their potential application as pH-responsive drug carriers. Journal of Sol-Gel Science and Technology. 91: 11-20. PMID 32863592 DOI: 10.1007/S10971-019-04995-4  0.332
2019 Anani T, Brannen A, Panizzi P, Duin EC, David AE. Quantitative, real-time in vivo tracking of magnetic nanoparticles using multispectral optoacoustic tomography (MSOT) imaging. Journal of Pharmaceutical and Biomedical Analysis. 112951. PMID 31718983 DOI: 10.1016/J.Jpba.2019.112951  0.393
2018 Zhou C, Choi YS, David AE, Todd PW, Hanley TR. Nanomaterial Endocytosis: Estimation of Particles Per Cell by Magnetic Measurement Ieee Magnetics Letters. 9: 1-5. DOI: 10.1109/Lmag.2018.2830754  0.338
2017 Zhou C, Qian Z, Choi YS, David AE, Todd P, Hanley TR. Application of magnetic carriers to two examples of quantitative cell analysis Journal of Magnetism and Magnetic Materials. 427: 25-28. DOI: 10.1016/J.Jmmm.2016.11.009  0.331
2017 Lee K, David AE, Zhang J, Shin MC, Yang VC. Enhanced accumulation of theranostic nanoparticles in brain tumor by external magnetic field mediated in situ clustering of magnetic nanoparticles Journal of Industrial and Engineering Chemistry. 54: 389-397. DOI: 10.1016/J.Jiec.2017.06.019  0.424
2016 Anani T, Panizzi P, David AE. Nanoparticle-based probes to enable noninvasive imaging of proteolytic activity for cancer diagnosis. Nanomedicine (London, England). PMID 27465386 DOI: 10.2217/Nnm-2016-0027  0.4
2016 Hanot CC, Choi YS, Anani TB, Soundarrajan D, David AE. Effects of Iron-Oxide Nanoparticle Surface Chemistry on Uptake Kinetics and Cytotoxicity in CHO-K1 Cells. International Journal of Molecular Sciences. 17. PMID 26729108 DOI: 10.3390/Ijms17010054  0.338
2015 Rogers HB, Anani T, Choi YS, Beyers RJ, David AE. Exploiting Size-Dependent Drag and Magnetic Forces forSize-Specific Separation of Magnetic Nanoparticles. International Journal of Molecular Sciences. 16: 20001-19. PMID 26307980 DOI: 10.3390/Ijms160820001  0.408
2015 Soheilian R, Choi YS, David AE, Abdi H, Maloney CE, Erb RM. Toward Accumulation of Magnetic Nanoparticles into Tissues of Small Porosity. Langmuir : the Acs Journal of Surfaces and Colloids. 31: 8267-74. PMID 26145706 DOI: 10.1021/Acs.Langmuir.5B01458  0.397
2014 Choi YS, David AE. Cell penetrating peptides and the mechanisms for intracellular entry. Current Pharmaceutical Biotechnology. 15: 192-9. PMID 24938895 DOI: 10.2174/1389201015666140617093331  0.356
2014 Shin MC, Zhang J, Min KA, Lee K, Byun Y, David AE, He H, Yang VC. Cell-penetrating peptides: achievements and challenges in application for cancer treatment. Journal of Biomedical Materials Research. Part A. 102: 575-87. PMID 23852939 DOI: 10.1002/Jbm.A.34859  0.398
2014 Choi YS, Lee MY, David AE, Park YS. Nanoparticles for gene delivery: Therapeutic and toxic effects Molecular and Cellular Toxicology. 10: 1-8. DOI: 10.1007/S13273-014-0001-3  0.364
2013 Zhang J, Shin MC, David AE, Zhou J, Lee K, He H, Yang VC. Long-circulating heparin-functionalized magnetic nanoparticles for potential application as a protein drug delivery platform. Molecular Pharmaceutics. 10: 3892-902. PMID 24024964 DOI: 10.1021/Mp400360Q  0.429
2013 Zhou J, Zhang J, David AE, Yang VC. Magnetic tumor targeting of β-glucosidase immobilized iron oxide nanoparticles. Nanotechnology. 24: 375102. PMID 23974977 DOI: 10.1088/0957-4484/24/37/375102  0.37
2013 Shin MC, Zhang J, David AE, Trommer WE, Kwon YM, Min KA, Kim JH, Yang VC. Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity. Journal of Controlled Release : Official Journal of the Controlled Release Society. 172: 169-78. PMID 23973813 DOI: 10.1016/J.Jconrel.2013.08.016  0.36
2013 Min KA, Shin MC, Yu F, Yang M, David AE, Yang VC, Rosania GR. Pulsed magnetic field improves the transport of iron oxide nanoparticles through cell barriers Acs Nano. 7: 2161-2171. PMID 23373613 DOI: 10.1021/Nn3057565  0.354
2013 He H, David A, Chertok B, Cole A, Lee K, Zhang J, Wang J, Huang Y, Yang VC. Magnetic nanoparticles for tumor imaging and therapy: a so-called theranostic system. Pharmaceutical Research. 30: 2445-58. PMID 23344909 DOI: 10.1007/S11095-013-0982-Y  0.437
2012 Wang J, Huang Y, David AE, Chertok B, Zhang L, Yu F, Yang VC. Magnetic nanoparticles for MRI of brain tumors. Current Pharmaceutical Biotechnology. 13: 2403-16. PMID 23016645 DOI: 10.2174/138920112803341824  0.396
2012 David AE, Gong J, Chertok B, Domszy RC, Moon C, Park YS, Wang NS, Yang AJ, Yang VC. Immobilized thermolysin for highly efficient production of low-molecular-weight protamine--an attractive cell-penetrating peptide for macromolecular drug delivery applications. Journal of Biomedical Materials Research. Part A. 100: 211-9. PMID 22042599 DOI: 10.1002/Jbm.A.33244  0.586
2011 David AE, Cole AJ, Yang VC. Magnetically targeted nanoparticles for brain tumor therapy: what does the future hold? Nanomedicine (London, England). 6: 1133-5. PMID 21929450 DOI: 10.2217/Nnm.11.99  0.339
2011 Chertok B, David AE, Yang VC. Brain tumor targeting of magnetic nanoparticles for potential drug delivery: effect of administration route and magnetic field topography. Journal of Controlled Release : Official Journal of the Controlled Release Society. 155: 393-9. PMID 21763736 DOI: 10.1016/J.Jconrel.2011.06.033  0.439
2011 Cole AJ, David AE, Wang J, Galbán CJ, Yang VC. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials. 32: 6291-301. PMID 21684593 DOI: 10.1016/J.Biomaterials.2011.05.024  0.439
2011 Chertok B, David AE, Yang VC. Magnetically-enabled and MR-monitored selective brain tumor protein delivery in rats via magnetic nanocarriers. Biomaterials. 32: 6245-53. PMID 21632104 DOI: 10.1016/J.Biomaterials.2011.05.004  0.413
2011 Cole AJ, Yang VC, David AE. Cancer theranostics: the rise of targeted magnetic nanoparticles. Trends in Biotechnology. 29: 323-32. PMID 21489647 DOI: 10.1016/J.Tibtech.2011.03.001  0.405
2011 David AE, Cole AJ, Chertok B, Park YS, Yang VC. A combined theoretical and in vitro modeling approach for predicting the magnetic capture and retention of magnetic nanoparticles in vivo. Journal of Controlled Release : Official Journal of the Controlled Release Society. 152: 67-75. PMID 21295085 DOI: 10.1016/J.Jconrel.2011.01.033  0.392
2011 Cole AJ, David AE, Wang J, Galbán CJ, Hill HL, Yang VC. Polyethylene glycol modified, cross-linked starch-coated iron oxide nanoparticles for enhanced magnetic tumor targeting. Biomaterials. 32: 2183-93. PMID 21176955 DOI: 10.1016/J.Biomaterials.2010.11.040  0.379
2011 David AE, Yang AJ, Wang NS. Enzyme stabilization and immobilization by sol-gel entrapment. Methods in Molecular Biology (Clifton, N.J.). 679: 49-66. PMID 20865388 DOI: 10.1007/978-1-60761-895-9_6  0.563
2010 Chertok B, David AE, Yang VC. Polyethyleneimine-modified iron oxide nanoparticles for brain tumor drug delivery using magnetic targeting and intra-carotid administration. Biomaterials. 31: 6317-24. PMID 20494439 DOI: 10.1016/J.Biomaterials.2010.04.043  0.445
2010 Yu F, Zhang L, Huang Y, Sun K, David AE, Yang VC. The magnetophoretic mobility and superparamagnetism of core-shell iron oxide nanoparticles with dual targeting and imaging functionality. Biomaterials. 31: 5842-8. PMID 20434209 DOI: 10.1016/J.Biomaterials.2010.03.072  0.434
2010 Huang Y, Park YS, Moon C, David AE, Chung HS, Yang VC. Synthetic skin-permeable proteins enabling needleless immunization. Angewandte Chemie (International Ed. in English). 49: 2724-7. PMID 20232417 DOI: 10.1002/Anie.200906153  0.311
2010 Chertok B, Cole AJ, David AE, Yang VC. Comparison of electron spin resonance spectroscopy and inductively-coupled plasma optical emission spectroscopy for biodistribution analysis of iron-oxide nanoparticles. Molecular Pharmaceutics. 7: 375-85. PMID 20039679 DOI: 10.1021/Mp900161H  0.379
2009 Zhang L, Yu F, Cole AJ, Chertok B, David AE, Wang J, Yang VC. Gum arabic-coated magnetic nanoparticles for potential application in simultaneous magnetic targeting and tumor imaging. The Aaps Journal. 11: 693-9. PMID 19842043 DOI: 10.1208/S12248-009-9151-Y  0.415
2009 Chertok B, David AE, Moffat BA, Yang VC. Substantiating in vivo magnetic brain tumor targeting of cationic iron oxide nanocarriers via adsorptive surface masking. Biomaterials. 30: 6780-7. PMID 19782394 DOI: 10.1016/J.Biomaterials.2009.08.040  0.457
2009 Kwon YM, Chung HS, Moon C, Yockman J, Park YJ, Gitlin SD, David AE, Yang VC. L-Asparaginase encapsulated intact erythrocytes for treatment of acute lymphoblastic leukemia (ALL). Journal of Controlled Release : Official Journal of the Controlled Release Society. 139: 182-9. PMID 19577600 DOI: 10.1016/J.Jconrel.2009.06.027  0.312
2008 Chertok B, Moffat BA, David AE, Yu F, Bergemann C, Ross BD, Yang VC. Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumors. Biomaterials. 29: 487-96. PMID 17964647 DOI: 10.1016/J.Biomaterials.2007.08.050  0.442
2008 Chertok B, David A, Yang V. Delivery of functional proteins to brain tumor using MRI-monitored, magnetically-targeted nanoparticles Journal of Controlled Release. 132: e61-e62. DOI: 10.1016/J.Jconrel.2008.09.058  0.42
2008 Chertok B, David AE, Yang VC. Strategies for enhanced brain tumor accumulation of magnetic nanoparticles for potential drug delivery Technical Proceedings of the 2008 Nsti Nanotechnology Conference and Trade Show, Nsti-Nanotech, Nanotechnology 2008. 2: 8-11.  0.318
2007 Chertok B, David AE, Huang Y, Yang VC. Glioma selectivity of magnetically targeted nanoparticles: a role of abnormal tumor hydrodynamics. Journal of Controlled Release : Official Journal of the Controlled Release Society. 122: 315-23. PMID 17628157 DOI: 10.1016/J.Jconrel.2007.05.030  0.422
2006 David AE, Wang NS, Yang VC, Yang AJ. Chemically surface modified gel (CSMG): an excellent enzyme-immobilization matrix for industrial processes. Journal of Biotechnology. 125: 395-407. PMID 16644049 DOI: 10.1016/J.Jbiotec.2006.03.019  0.56
2005 Wang T, Yang Z, Emregul E, David A, Balthasar JP, Liang J, Yang VC. Strategies for improving the functionality of an affinity bioreactor. International Journal of Pharmaceutics. 306: 132-41. PMID 16246511 DOI: 10.1016/J.Ijpharm.2005.09.011  0.303
Show low-probability matches.